معرفی
Katie Reindl is a Professor in the Department of Biological Sciences at North Dakota State University (NDSU). Her research focuses on understanding the molecular mechanisms driving changes in gene and protein expression during cancer progression and identifying pharmacological targets for cancer treatment, particularly in pancreatic ductal adenocarcinoma. She explores signaling pathways such as ERK and PI3K, as well as drug delivery strategies using nanotechnology and targeted therapies.
Her work integrates molecular biology, pharmacology, and computational modeling to address challenges in cancer biology. Key areas include ER stress responses, mitochondrial dynamics, and tumor microenvironment interactions. She has contributed to advancements in combination therapies, drug delivery systems, and biomimetic tumor models.
Dr. Reindl’s research emphasizes translational applications, aiming to bridge laboratory findings with clinical relevance. Her studies often involve multi-omics analyses and collaborative approaches to uncover novel therapeutic targets and improve treatment efficacy.
